Global CAR T-Cell Therapy Competitive Landscape Professional Research Report 2024
Research Summary
CAR T-cell therapy, or Chimeric Antigen Receptor T-cell therapy, is an innovative immunotherapy approach used to treat certain types of cancer, particularly blood cancers like leukemia and lymphoma. In CAR T-cell therapy, a patient＇s own T cells (a type of immune cell) are collected from their blood and then genetically engineered to express a chimeric antigen receptor (CAR) on their surface. This receptor is designed to recognize and target a specific protein found on the cancer cells. Once the CAR T cells are modified, they are multiplied in the laboratory and then infused back into the patient＇s bloodstream. These engineered T cells can now identify and attack cancer cells, effectively enhancing the immune system＇s ability to combat the disease. CAR T-cell therapy has shown remarkable success in some patients with otherwise challenging-to-treat blood cancers, leading to complete or partial remissions and offering new hope in the field of cancer treatment.
According to DIResearch's in-depth investigation and research, the global CAR T-Cell Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of CAR T-Cell Therapy include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline) etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of CAR T-Cell Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CAR T-Cell Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CAR T-Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CAR T-Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of CAR T-Cell Therapy Include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
Johnson & Johnson
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
CAR T-Cell Therapy Product Segment Include:
CD19 - Targeted
BCMA - Targeted
CAR T-Cell Therapy Product Application Include:
Lymphoma
Multiple Myeloma
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global CAR T-Cell Therapy Industry PESTEL Analysis
Chapter 3: Global CAR T-Cell Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global CAR T-Cell Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global CAR T-Cell Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global CAR T-Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 CAR T-Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CAR T-Cell Therapy Product by Type
- 1.2.1 Global CAR T-Cell Therapy Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 CD19 - Targeted
- 1.2.3 BCMA - Targeted
- 1.3 CAR T-Cell Therapy Product by Application
- 1.3.1 Global CAR T-Cell Therapy Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Lymphoma
- 1.3.3 Multiple Myeloma
- 1.4 Global CAR T-Cell Therapy Market Revenue Analysis (2019-2030)
- 1.5 CAR T-Cell Therapy Market Development Status and Trends
- 1.5.1 CAR T-Cell Therapy Industry Development Status Analysis
- 1.5.2 CAR T-Cell Therapy Industry Development Trends Analysis
- 2 CAR T-Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CAR T-Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CAR T-Cell Therapy Market Analysis by Regions
- 4.1 CAR T-Cell Therapy Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global CAR T-Cell Therapy Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global CAR T-Cell Therapy Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global CAR T-Cell Therapy Revenue Forecast by Region (2025-2030)
- 5 Global CAR T-Cell Therapy Market Size by Type and Application
- 5.1 Global CAR T-Cell Therapy Market Size by Type
- 5.2 Global CAR T-Cell Therapy Market Size by Application
- 6 North America
- 6.1 North America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America CAR T-Cell Therapy Market Size by Type
- 6.4 North America CAR T-Cell Therapy Market Size by Application
- 6.5 North America CAR T-Cell Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe CAR T-Cell Therapy Market Size by Type
- 7.4 Europe CAR T-Cell Therapy Market Size by Application
- 7.5 Europe CAR T-Cell Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China CAR T-Cell Therapy Market Size by Type
- 8.4 China CAR T-Cell Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) CAR T-Cell Therapy Market Size by Type
- 9.4 APAC (excl. China) CAR T-Cell Therapy Market Size by Application
- 9.5 APAC (excl. China) CAR T-Cell Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America CAR T-Cell Therapy Market Size by Type
- 10.4 Latin America CAR T-Cell Therapy Market Size by Application
- 10.5 Latin America CAR T-Cell Therapy Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa CAR T-Cell Therapy Market Size by Type
- 11.4 Middle East & Africa CAR T-Cell Therapy Market Size by Application
- 11.5 Middle East & Africa CAR T-Cell Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global CAR T-Cell Therapy Market Revenue by Key Manufacturers (2020-2024)
- 12.2 CAR T-Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 CAR T-Cell Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Novartis
- 13.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Novartis CAR T-Cell Therapy Product Portfolio
- 13.1.3 Novartis CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Gilead Sciences
- 13.2.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Gilead Sciences CAR T-Cell Therapy Product Portfolio
- 13.2.3 Gilead Sciences CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Bristol-Myers Squibb
- 13.3.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Portfolio
- 13.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson CAR T-Cell Therapy Product Portfolio
- 13.4.3 Johnson & Johnson CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 JW Therapeutics
- 13.5.1 JW Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 JW Therapeutics CAR T-Cell Therapy Product Portfolio
- 13.5.3 JW Therapeutics CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 FOSUNKite
- 13.6.1 FOSUNKite Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 FOSUNKite CAR T-Cell Therapy Product Portfolio
- 13.6.3 FOSUNKite CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 CARsgen Therapeutics (Pipeline)
- 13.7.1 CARsgen Therapeutics (Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Autolus Therapeutics(Pipeline)
- 13.8.1 Autolus Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Sorrento Therapeutics(Pipeline)
- 13.9.1 Sorrento Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Mustang Bio(Pipeline)
- 13.10.1 Mustang Bio(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Bluebird Bio(Pipeline)
- 13.11.1 Bluebird Bio(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Cellectis(Pipeline)
- 13.12.1 Cellectis(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.13 Allogene Therapeutics(Pipeline)
- 13.13.1 Allogene Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.14 Celyad(Pipeline)
- 13.14.1 Celyad(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Portfolio
- 13.14.3 Celyad(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 CAR T-Cell Therapy Industry Chain Analysis
- 14.2 CAR T-Cell Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 CAR T-Cell Therapy Typical Downstream Customers
- 14.4 CAR T-Cell Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook